2023 Chinese pneumonia outbreak

Last updated

2023 Chinese pneumonia outbreak
Liaoning in China (+all claims hatched).svg
Map of Liaoning, a province affected by the outbreak
Disease Pneumonia
Locationnorthern China
Index case Dalian, China
DateNovember 2023 – present

In November 2023, China's health authorities reported an outbreak of respiratory illnesses in several parts of northern China. [1] As hospitals became overwhelmed in Beijing and Liaoning, [2] the World Health Organization (WHO) requested detailed information from China regarding the surges in respiratory health, while advising the community to take important precautions. [3] China complied, responding that "no unusual or novel pathogens were found" in the provided data. [4]

Contents

As of 23 November 2023, the cause of the outbreak is unknown. Possible reasons include known seasonal diseases and the lifting of COVID-19 restrictions. [4]

Timeline

May–October 2023

As reported in China Daily , an increase of mycoplasma pneumoniae infections in China was observed in May 2023 by Zhou Huixia, director of a children's medical centre, with a "rapid increase" in August and a "particularly ferocious" wave starting in early October. On 24 October 2023, Zhou predicted that the wave would peak in November. [5]

November 2023

On 13 November, authorities from China's National Health Commission reported an increase in respiratory diseases. The increase in these diseases was attributed to the lifting of COVID-19 restrictions earlier in the year, and the circulation of known pathogens including influenza, mycoplasma pneumoniae (a common bacterial infection typically affecting young children), respiratory syncytial virus (RSV), and SARS-CoV-2. [6]

On 21 November, ProMED reported clusters of undiagnosed pneumonia in children in northern China. It is unclear if these are associated with the overall increase in respiratory infections previously reported by Chinese authorities or separate events. Further information about recent trends in these known pathogens was requested by the WHO. [6] The WHO stated that during October and November, northern China had reported an "increase in influenza-like illness" compared to the corresponding period during the previous three years. [7]

On 23 November, Chinese health authorities claimed that the increase in respiratory diseases was not attributed to any novel or unknown pathogens but was relevant to known pathogens. Later, WHO verifies that no novel or unknown pathogens have been discovered so far, and the clinical features of the diseases are not unusual. [8]

On 27 November, a journal article published in Nature indicated that there are many multiple anomalies behind the dramatic increase in respiratory disease cases in China. First, usually, the infection caused by Mycoplasma pneumoniae is easy to treat, but, in this case in China, the infection causes serious impact on Chinese children. Second, after the lifting of COVID-19 restrictions, cases reported by some of the countries are virus infections; in contrast, the major cases reported by China, particularly, are mycoplasma pneumoniae, a disease whose infection is caused by bacteria. [9]

Other pneumonia outbreaks in late 2023

In late November 2023, Russian children's hospitals and infectious diseases hospitals in Moscow and St. Petersburg noticed a significant increase of mycoplasma pneumonia in patients with acute respiratory infections. The outbreak will likely complicate already expected epidemics such as those caused by the coronavirus, influenza A and respiratory syncytial viruses. [10] As of December, large queues of ambulances have been reported to have formed in front of Infectious Diseases Hospitals No. 1 and No. 2 in Moscow. [11]

A similar outbreak occurred in Ohio in the United States in late 2023. As of December 2023, Céline Gounder, an infectious disease specialist stated that the outbreaks were similar but unrelated. [12]

Denmark reported an pneumonia outbreak. As of November 2023, 541 cases had been identified. [13]

The Philippines Department of Health reported four confirmed cases of mycoplasma pneumoniae among reported influenza-like illnesses as of 25 November. [14]

Related Research Articles

<span class="mw-page-title-main">Pneumonia</span> Inflammation of the alveoli of the lungs

Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. Symptoms typically include some combination of productive or dry cough, chest pain, fever, and difficulty breathing. The severity of the condition is variable.

<span class="mw-page-title-main">SARS</span> Disease caused by severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.

Atypical pneumonia, also known as walking pneumonia, is any type of pneumonia not caused by one of the pathogens most commonly associated with the disease. Its clinical presentation contrasts to that of "typical" pneumonia. A variety of microorganisms can cause it. When it develops independently from another disease, it is called primary atypical pneumonia (PAP).

Mycoplasma pneumoniae is a very small bacterium in the class Mollicutes. It is a human pathogen that causes the disease mycoplasma pneumonia, a form of atypical bacterial pneumonia related to cold agglutinin disease. M. pneumoniae is characterized by the absence of a peptidoglycan cell wall and resulting resistance to many antibacterial agents. The persistence of M. pneumoniae infections even after treatment is associated with its ability to mimic host cell surface composition.

<span class="mw-page-title-main">Lower respiratory tract infection</span> Medical term

Lower respiratory tract infection (LRTI) is a term often used as a synonym for pneumonia but can also be applied to other types of infection including lung abscess and acute bronchitis. Symptoms include shortness of breath, weakness, fever, coughing and fatigue. A routine chest X-ray is not always necessary for people who have symptoms of a lower respiratory tract infection.

Mycoplasma pneumonia is a form of bacterial pneumonia caused by the bacterium Mycoplasma pneumoniae.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

Community-acquired pneumonia (CAP) refers to pneumonia contracted by a person outside of the healthcare system. In contrast, hospital-acquired pneumonia (HAP) is seen in patients who have recently visited a hospital or who live in long-term care facilities. CAP is common, affecting people of all ages, and its symptoms occur as a result of oxygen-absorbing areas of the lung (alveoli) filling with fluid. This inhibits lung function, causing dyspnea, fever, chest pains and cough.

<span class="mw-page-title-main">Canine influenza</span>

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

<span class="mw-page-title-main">Hospital-acquired pneumonia</span>

Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus.

<span class="mw-page-title-main">Influenza</span> Infectious disease

Influenza, commonly known as "the flu" or just "flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, nausea, and sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

The 2009 flu pandemic was a global outbreak of a new strain of influenza A virus subtype H1N1, first identified in April 2009, termed Pandemic H1N1/09 virus by the World Health Organization (WHO) and colloquially called swine flu. The outbreak was first observed in Mexico, and quickly spread globally. On the 11th of June 2009, the WHO declared the outbreak to be a pandemic. The overwhelming majority of patients experience mild symptoms, but some persons are at higher risk of suffering more serious effects; such as those with asthma, diabetes, obesity, heart disease, or those who are pregnant or have a weakened immune system. In the rare severe cases, around 3–5 days after symptoms manifest, the sufferer's condition declines quickly, often to the point respiratory failure. Although Ukraine was not (very) affected at first there was on outbreak of the virus in Western Ukraine in early November 2009 that led to the closing of public buildings and cancellation of meetings for three weeks.

<span class="mw-page-title-main">Robert M. Chanock</span> American pediatrician and virologist

Robert Merritt Chanock was an American pediatrician and virologist who made major contributions to the prevention and treatment of childhood respiratory infections in more than 50 years spent at the National Institute of Allergy and Infectious Diseases.

<span class="mw-page-title-main">Classification of pneumonia</span> Medical condition

Pneumonia can be classified in several ways, most commonly by where it was acquired, but may also by the area of lung affected or by the causative organism. There is also a combined clinical classification, which combines factors such as age, risk factors for certain microorganisms, the presence of underlying lung disease or systemic disease and whether the person has recently been hospitalized.

Chronic Mycoplasma pneumonia and Chlamydia pneumonia infections are associated with the onset and exacerbation of asthma. These microbial infections result in chronic lower airway inflammation, impaired mucociliary clearance, an increase in mucous production and eventually asthma. Furthermore, children who experience severe viral respiratory infections early in life have a high possibility of having asthma later in their childhood. These viral respiratory infections are mostly caused by respiratory syncytial virus (RSV) and human rhinovirus (HRV). Although RSV infections increase the risk of asthma in early childhood, the association between asthma and RSV decreases with increasing age. HRV on the other hand is an important cause of bronchiolitis and is strongly associated with asthma development. In children and adults with established asthma, viral upper respiratory tract infections (URIs), especially HRVs infections, can produce acute exacerbations of asthma. Thus, Chlamydia pneumoniae, Mycoplasma pneumoniae and human rhinoviruses are microbes that play a major role in non-atopic asthma.

Necrotizing pneumonia (NP), also known as cavitary pneumonia or cavitatory necrosis, is a rare but severe complication of lung parenchymal infection. In necrotizing pneumonia, there is a substantial liquefaction following death of the lung tissue, which may lead to gangrene formation in the lung. In most cases patients with NP have fever, cough and bad breath, and those with more indolent infections have weight loss. Often patients clinically present with acute respiratory failure. The most common pathogens responsible for NP are Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae. Diagnosis is usually done by chest imaging, e.g. chest X-ray, CT scan. Among these CT scan is the most sensitive test which shows loss of lung architecture and multiple small thin walled cavities. Often cultures from bronchoalveolar lavage and blood may be done for identification of the causative organism(s). It is primarily managed by supportive care along with appropriate antibiotics. However, if patient develops severe complications like sepsis or fails to medical therapy, surgical resection is a reasonable option for saving life.

<span class="mw-page-title-main">2022–2023 pediatric care crisis</span> Ongoing viral disease outbreak

In the waning months of 2022, the first northern hemisphere autumn with the nearly full relaxation of public health precautions related to the COVID-19 pandemic, hospitals in the United States and Canada began to see overwhelming numbers of pediatric care patients, primarily driven by a massive upswing in respiratory syncytial virus (RSV) cases, but also flu, rhinovirus, enterovirus, and SARS-CoV-2.

In late 2023, an outbreak of mycoplasma pneumonia occurred in Ohio in the United States, primarily affecting children. Despite it occurring at around the same time, experts say that it is unrelated to the 2023 Chinese pneumonia outbreak. The average age of children affected is eight years old, with some cases being as young as three. As of December 1, 2023, investigation as to the cause is still ongoing.

References

  1. "WHO asks China for details on respiratory illness outbreaks". Reuters. 23 November 2023. Archived from the original on 29 November 2023. Retrieved 23 November 2023.
  2. "Large outbreak of pneumonia in China, pediatric hospitals in Beijing, Liaoning overwhelmed | Forexlive". Forexlive | Forex News, Technical Analysis & Trading Tools. Archived from the original on 29 November 2023. Retrieved 23 November 2023.
  3. "WHO advises Chinese to take measures amid respiratoy illness spike". The Times of India. Agence France-Presse. 23 November 2023. Archived from the original on 29 November 2023. Retrieved 23 November 2023.
  4. 1 2 Beasley, Deena; Silver, Andrew; Rigby, Jennifer; Farge, Emma; Birsel, Robert; Kim, Miyoung; Kao, Josie. "China says no unusual pathogens found after WHO queries respiratory outbreaks". Reuters. Archived from the original on 29 November 2023. Retrieved 23 November 2023.
  5. "Calm urged as pneumonia cases in children increase". China Daily . 24 October 2023. ISSN   0253-9543. Wikidata   Q123559915. Archived from the original on 27 November 2023.
  6. 1 2 "WHO statement on reported clusters of respiratory illness in children in northern China". WHO. Archived from the original on 2 December 2023. Retrieved 23 November 2023.
  7. Chatterjee, Phelan; Walsh, Fergus; Mazumdar, Tulip (23 November 2023). "China says no 'unusual or novel pathogens' after WHO queries respiratory outbreaks". BBC . Archived from the original on 25 November 2023. Retrieved 25 November 2023.
  8. Chakraborty, Deblina (28 November 2023). "How concerning is the spike in respiratory illnesses in China? A doctor explains". CNN. Archived from the original on 2 December 2023. Retrieved 3 December 2023.
  9. Conroy, Gemma (27 November 2023). "What's behind China's mysterious wave of childhood pneumonia?". Nature. doi:10.1038/d41586-023-03732-w. PMID   38012356. S2CID   265464001. Archived from the original on 5 December 2023. Retrieved 6 December 2023.
  10. Maria Frolova, Andrey Korshunov, Yana Sturma (6 December 2023). "Болеют дети: в России выросло число случаев микоплазменной пневмонии" [Children are getting sick: The number of cases of mycoplasma pneumonia has increased in Russia]. Retrieved 21 December 2023.{{cite web}}: CS1 maint: multiple names: authors list (link)
  11. "Russia Denies Mystery Virus Outbreak as Video Shows Row of Ambulances". newsweek.com. 18 December 2023.
  12. "Ohio "white lung" pneumonia cases not linked to China outbreak or novel pathogen, experts say - CBS News". www.cbsnews.com. 1 December 2023. Archived from the original on 5 December 2023. Retrieved 2 December 2023.
  13. "Denmark reports Mycoplasma pneumonia epidemic". 30 November 2023. Retrieved 6 December 2023.
  14. "4 cases of walking pneumonia detected in Philippines: DOH". 6 December 2023. Retrieved 6 December 2023.